HomeBook
Detox

Insulin Resistance Can Hide Behind Perfectly Normal Labs

· 7 min read

A patient sits across from me with a stack of lab results, all of them flagged normal, and a list of symptoms that says otherwise: stubborn weight around the middle, energy that crashes hard an hour after eating, carbohydrate cravings that feel less like preference and more like compulsion. The standard annual physical checked fasting glucose, and it came back fine, so the conversation ended there. That's the problem with using fasting glucose as the marker for metabolic health: it is one of the last things to change, not one of the first. Insulin resistance, the process underneath it, can be well established for years before glucose itself ever moves out of the normal range.

The Number Nobody Orders

Insulin is released by the pancreas whenever blood glucose rises, and its job is to signal cells throughout the body, primarily in muscle, liver, and fat tissue, to take that glucose up and use or store it. In insulin resistance, those cells stop responding normally to the signal. The pancreas compensates the only way it can: by producing more insulin. For a long stretch of time, that compensation works. Blood glucose stays in a technically normal range because the pancreas is quietly working much harder to keep it there. Fasting glucose only starts to climb once beta cell output can no longer keep pace with the resistance, which is a late-stage sign, not an early one.

The marker that actually catches this earlier is fasting insulin, measured alongside fasting glucose and used to calculate HOMA-IR (homeostatic model assessment of insulin resistance). A HOMA-IR above roughly 2.0 suggests developing resistance; above 2.5 indicates it's established. Almost nobody has this calculated as part of a routine physical, because fasting insulin isn't part of the standard panel most physicians order. A two-hour glucose tolerance test with insulin measured at baseline, one hour, and two hours is more sensitive still, and it's the test I reach for when someone's symptom picture doesn't match their fasting numbers.

What Hyperinsulinemia Actually Does

Chronically elevated insulin isn't a neutral bystander waiting for glucose to eventually rise. It's actively doing things to the body the whole time it's elevated. It promotes fat storage, particularly visceral fat around the abdomen, and it does so preferentially over fat mobilization, which is a large part of why insulin resistance and difficulty losing weight travel together so reliably. It drives low-grade systemic inflammation, and it stimulates androgen production directly in the ovaries, which is the central mechanism behind the acne, irregular cycles, and hair changes seen in PCOS. In men, the same hyperinsulinemia suppresses testosterone production, contributing to a pattern of low energy and reduced muscle mass that often gets attributed to age rather than to a metabolic driver that's actually addressable.

The vascular and lipid effects are just as significant, even though they're less visible day to day. Insulin resistance shifts LDL particle size toward the smaller, denser, more atherogenic form and raises triglycerides independent of dietary fat intake. It also pushes the sympathetic nervous system toward sustained activation, one of the mechanisms behind insulin-resistance-driven hypertension. Left unaddressed, the whole process progresses in a fairly predictable arc, from insulin resistance to prediabetes to type 2 diabetes, with beta cell function eroding a little further at each stage. None of that arc is inevitable, but none of it announces itself loudly enough for most people to notice until it's fairly advanced.

Why It Develops

Skeletal muscle is the single largest site of glucose disposal in the body, which means physical inactivity is one of the most direct drivers of insulin resistance there is: without regular resistance exercise, the tissue best equipped to clear glucose from the bloodstream simply isn't doing its job. Excess visceral fat compounds this, since visceral adipose tissue is metabolically active in ways that worsen insulin signalling throughout the body, not just locally. A diet heavy in refined carbohydrates and sugar chronically spikes insulin and, over time, drives the receptor downregulation that defines resistance in the first place.

Sleep is a less obvious but genuinely major factor. Even a single week of five to six hours of sleep produces a measurable drop in insulin sensitivity, in the range of what you'd expect from gaining eight to ten pounds of body fat. Chronic stress works through a related pathway: cortisol directly opposes insulin signalling, so a nervous system that stays activated keeps working against whatever else is being done nutritionally. Gut dysbiosis, particularly a reduction in butyrate-producing bacteria, impairs glucose metabolism through the gut-liver axis in ways that are increasingly well documented but still rarely investigated. And certain medications, corticosteroids, some antipsychotics, and several blood pressure drugs among them, induce insulin resistance as a known side effect, which is worth flagging rather than assuming the metabolic picture is purely lifestyle-driven.

The Testing That Catches It Years Earlier

A comprehensive metabolic workup doesn't stop at fasting glucose. It includes fasting insulin to calculate HOMA-IR, ideally a two-hour glucose tolerance test with insulin at baseline, one hour, and two hours for anyone whose symptoms suggest resistance despite normal fasting numbers, and HbA1c to reflect average glucose exposure over the preceding three months. I pair this with a full lipid panel that includes small dense LDL, inflammatory markers, and liver enzymes, since insulin resistance frequently coexists with early fatty liver changes that are themselves worth catching early.

Symptoms are a useful clinical prompt for ordering this panel in the first place: fatigue that hits hard after carbohydrate-heavy meals, cravings that feel disproportionate to actual hunger, difficulty losing weight despite consistent effort, and central weight gain in particular. None of these confirm insulin resistance on their own, but in someone whose fasting glucose looks fine, they're reason enough to ask for the fasting insulin and HOMA-IR that standard care usually skips.

Muscle Is the Best Lever You Have

If there's one intervention I'd ask a patient with insulin resistance to prioritize above all others, it's resistance training, not because it's the only thing that matters, but because it works on the actual mechanism more directly than anything else available. Skeletal muscle is the body's largest glucose sink, and building more of it, along with using what's already there more consistently, permanently improves the capacity to clear glucose from circulation. This is a structural change to metabolic capacity, not a temporary shift, which is part of why its effects tend to be more durable than dietary intervention alone.

Dietary protein prioritized at each meal, alongside a meaningful reduction in refined carbohydrates, produces a measurably better post-meal insulin response almost immediately, and it pairs directly with the muscle-building side of the equation since adequate protein is what resistance training actually needs to work with. In my clinical experience, patients who commit to consistent resistance training and protein-forward eating see HOMA-IR normalize within three to six months in the majority of cases, even before any supplement is added to the picture. More advanced metabolic disease takes longer, but it remains significantly reversible with sustained effort.

Where Berberine, Inositol, and Fasting Fit

Berberine has a genuinely strong evidence base here: multiple head-to-head trials show effects on fasting glucose, HbA1c, and insulin sensitivity comparable to metformin, with the added benefit of favourable effects on lipids and the gut microbiome. I use it selectively, particularly for patients who've had gastrointestinal side effects with metformin or who prefer to start with a non-pharmaceutical option while the foundational lifestyle work is underway. Inositol, specifically myo-inositol combined with D-chiro-inositol in physiological ratios, directly supports the insulin signalling pathway at the cellular level and has particularly good evidence in PCOS-driven insulin resistance. Both are the kind of targeted supplementation that earns its place once the underlying mechanism has actually been identified through proper testing, rather than taken speculatively.

Structured intermittent fasting protocols reduce total insulin exposure across the day and, for many patients, meaningfully improve receptor sensitivity over a period of weeks, though they're not appropriate for everyone and I tailor the eating window to the individual rather than defaulting to a single protocol. None of this replaces addressing sleep and cortisol directly. A patient who fixes their diet and starts lifting weights but is still sleeping five hours a night and running on chronic stress will plateau well short of where they could otherwise get to, because those two factors work against insulin sensitivity through mechanisms that diet and exercise alone don't touch.

Key Takeaways

  • Fasting glucose is a late marker; insulin resistance can be well established for years before it moves out of the normal range.
  • Fasting insulin combined with fasting glucose calculates HOMA-IR, a marker that catches insulin resistance far earlier, and it's rarely ordered as part of routine bloodwork.
  • Chronically elevated insulin drives visceral fat storage, inflammation, androgen excess in PCOS, suppressed testosterone in men, and a shift toward smaller, more atherogenic LDL particles.
  • Physical inactivity, refined carbohydrate intake, poor sleep, chronic stress, and gut dysbiosis are the most common, correctable drivers.
  • Resistance training is the single most direct intervention, since skeletal muscle is the body's largest site of glucose disposal, and most patients see HOMA-IR normalize within three to six months of consistent effort.
  • Berberine and inositol both have solid clinical evidence as targeted additions once testing confirms the mechanism, but neither replaces addressing sleep and stress directly.
Dr. Rigobert Kefferputz

Dr. Rigobert Kefferputz, ND

Naturopathic doctor on Salt Spring Island with over 14 years of clinical experience in integrative medicine. McGill University and Boucher Institute of Naturopathic Medicine graduate. Member of the Canadian Association of Naturopathic Doctors.

References & Further Reading

This article is for education and is not a substitute for individual medical advice. For background reading, these independent health authorities offer evidence-based information:

Ready to get started?

Book a consultation and I'll build a treatment plan tailored to your health goals.